Trials / Completed
CompletedNCT01796691
The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)
Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- Ruhr University of Bochum · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparing standard treatment versus optimized antiplatelet therapy and outcomes measures.
Detailed description
The study is aimed to evaluate if optimized antiplatelet treatment using a test and treat algorithm (with whole blood aggregometry) is able to improve clinical outcome of patients compared to standard treatment without platelet function testing.
Conditions
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2013-02-22
- Last updated
- 2013-02-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01796691. Inclusion in this directory is not an endorsement.